Artificial intelligence paradigm for ligand-based virtual screening on the drug discovery of type 2 diabetes mellitus
Abstract Background New dipeptidyl peptidase-4 (DPP-4) inhibitors need to be developed to be used as agents with low adverse effects for the treatment of type 2 diabetes mellitus. This study aims to build quantitative structure-activity relationship (QSAR) models using the artificial intelligence pa...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-05-01
|
Series: | Journal of Big Data |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40537-021-00465-3 |